Datopotamab deruxtecan

• Target:

  Topoisomerase|||Antibody-Drug Conjugates (ADCs) |||TROP2

• Related Pathways:

  Antibody-drug Conjugate/ADC Related|||Immunology/Inflammation|||DNA Damage/DNA Repair

• Purity:

  0.9846

• Bioactivity:

  Datopotamab deruxtecan (DS-1062) is a trophoblast cell surface antigen 2 (TROP2) -targeted antibody-drug conjugate (ADC) with antitumor activity. Datopotamab deruxtecan induces significant antibody-dependent cellular cytotoxicity in the presence of peripheral blood lymphocytes and inhibits tumor growth in xenograft models.

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  2238831-60-0